Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
Methyl 4-(4-Fluorophenyl)-2,6-diisopropyl-5-methoxynicotinate is an intermediate in the synthesis of Cerivastatin Sodium Salt (C277000), which is a competitive inhibitor of HMG-CoA reductase.
您的位置：
